Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cross Country Healthcare Inc Issues Q3 2013 Guidance Below Analysts' Estimates


Tuesday, 6 Aug 2013 05:08pm EDT 

Cross Country Healthcare Inc announced that for the third quarter of 2013, it expects revenue to be in the $110.0 million to $112.0 million range and EPS per diluted share from continuing operations to be in the range of negative $0.02 to $0.00. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $114 million and EPS of $0.02 for the third quarter of 2013. 

Company Quote

13.34
0.68 +5.37%
24 Dec 2014